Ticker
WHWKCompany Name
WHITEHAWK THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 180.82M | $ 144.94M | 80.15% |
3/31/2025 | $ 234M | $ 227.57M | 97.25% |
12/31/2024 | $ 70.32M | $ 28.67M | 40.77% |
9/30/2024 | $ 85.7M | $ 30.54M | 35.63% |
6/30/2024 | $ 101.62M | $ 41.14M | 40.48% |
3/31/2024 | $ 111.07M | $ 53.78M | 48.42% |
12/31/2023 | $ 132.42M | $ 62.89M | 47.49% |
9/30/2023 | $ 139.66M | $ 68.8M | 49.26% |
6/30/2023 | $ 151.23M | $ 68.16M | 45.07% |
3/31/2023 | $ 170.65M | $ 34.05M | 19.95% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for WHITEHAWK THERAPEUTICS INC is calculated as follows: CashnEq [ $ 47.3M ] / Assets [ $ 49.83M ]
(=) Cash to Assets [ 94.93% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |